From financialisation to innovation in UK Big Pharma : AstraZeneca and GlaxoSmithKline / Oner Tulum, Antonio Andreoni, William Lazonick
Material type:
Computer fileSeries: Cambridge elements. Elements in reinventing capitalism 2634-8950 | Cambridge elements. Elements in reinventing capitalismPublication details: Cambridge : Cambridge University Press, 2022Notes: Title from publisher's bibliographic system (viewed on 30 Nov 2022)Description: online resourceISBN: - 9781009278140
- HD 9667.9.A78 T84F 2022
| Item type | Current library | Collection | Shelving location | Call number | Status | Barcode | |
|---|---|---|---|---|---|---|---|
E-Book
|
SPU Library, Bangkok (Main Campus) | Electronic Resources | On Display | HD 9667.9.A78 T84F 2022 (Browse shelf(Opens below)) | Available | EB000395 |
Title from publisher's bibliographic system (viewed on 30 Nov 2022)
1. Introduction -- 2. Innovation and Competition in the Global Pharmaceutical Industry -- 3. The Innovation-Financialisation Tension in the Global Pharmaceutical Industry -- 4. AstraZeneca -- 5. GlaxoSmithKline -- 6. Explaining the Financialisation-to-Innovation Transition at AstraZeneca and GlaxoSmithKline
There are no comments on this title.
Click on an image to view it in the image viewer